In honor of National Healthy Skin Month, it is the perfect time to encourage patients to integrate gentle laser treatments into their yearly routine to maintain healthy, radiant skin.
In recent years, laser technology has undergone significant advancements, expanding the range of available lasers for various applications. Lasers are specifically designed to target different tissue typeswith water, hemoglobin, and pigment being the most common chromophores.1
Lasers come in2 categories: ablative and nonablative. Ablative lasers vaporize tissue at the level of the epidermis in a fractionated or fully ablative manner, which is a very effective technique for skin rejuvenation; however, increased downtime, infection risk, and persistent erythema are all potential adverse effects.
Nonablative lasers deliver less thermal injury and promote dermal wound healing while protecting the stratum corneum through precise penetrating waves and cooling mechanisms.2This process, known as photothermolysis, generates heat at the dermal level, stimulating collagen and elastin production and, in some cases, scar remodeling.1,3Nonablative fractional lasers (NAFLs) achieve this by using thousands of tiny, deep columns to deliver preciseheat levels.4
Nonablative lasers can also have specific targets, such as hemoglobin and pigment. Many of these devices are used to treat redness, photoaging, and unwanted tattoos with minimal downtime due to preservation of the skin barrier.2,5See theTable1,2for a comparison of both typesof lasers.
Skin cancer is the most prevalent cancer in the United States and that more than3 million Americans are diagnosed with nonmelanoma skin cancers each year.6Repeated exposure increases the risk of developing nonmelanoma skin cancers, such as basal cell carcinoma and squamous cell carcinoma. These2 types of cancer are collectively known as keratinocytecarcinoma (KC).
In individuals with a history of prior KC, the risk of developing subsequent KC remains a significant concern. This risk is particularly pronounced in the5 years following the initial diagnosis. For instance, within3 years post diagnosis, there is a 35% probability of developing another KC, and this risk escalates to as much as 50% within a 5-year period. Factors that contribute to an increased risk of KC include being male, being older than 60 years, having a history of multiple previous skin cancers, and having substantial actinic skin damage or skin that is prone to sunburn.7
According to the American Society for Dermatologic Surgery, even precancerous skin lesions such as actinic keratosis and actinic cheilitis have the ability to transform into squamous cell carcinoma.8There is, however, good news for those who already have sun-damaged skin and are looking to improve the overall health of their skin. A recent retrospective study conducted at the Massachusetts General Hospital Dermatology Laser and Cosmetic Center in Boston found that in patients treated with NAFLs for facial KCs, only 20.9% subsequently developed a KC, whereas the control group had a 40.4% rate of subsequent KC development. After accounting for age, gender, and skin type, individuals in the control group had a higher likelihood of developing new facial KC compared with patients who underwent laser treatment.9
In 2014, a study in theJournal of Cosmetic and Laser Therapyexamined a group of 10 female participants. These individuals, ranging in age from 35 to 53 years and with skin types I to IV, exhibited mild to moderate facial photodamage. This photodamage was characterized by various features, including hyperpigmentation, telangiectasia, skin laxity, skin roughness, and actinic keratosis. These individuals underwent a series of treatments using a nonablative fractional Q-switched 1064-nm Nd:YAG laser. The therapeutic regimen included4 sessions spaced at 2- to 4-week intervals, with follow-up assessments at1 and3 months after the final treatment session.
Baseline assessments using the Glogau scale revealed that6 participants were classified as type II (indicating wrinkles in motion), and4 participants were designated as type III (indicating wrinkles at rest). Impressively, at the 3-month follow-up after the final session, 60% of participants exhibited a notable 1-point or greater enhancement in their overall Glogau scale score. Moreover, it was observed during the study that the laser treatments resulted in substantial improvements in various skin irregularities: Hyperpigmentation decreased by 70%, telangiectasias by 80%, laxity by 80%, tactile roughness by 60%, and actinic keratoses by 60%. The investigators concluded that the nonablative fractional Q-switched 1064-nm Nd:YAG laser demonstrated both safety and efficacy in ameliorating mild to moderate photodamage with minimal downtime and discomfort and without any discernibleadverse effects.10
In a 2021 study published in the same journal, researchers investigated the safety and effectiveness of a 1565-nm NAFL for addressing facial photoaging. Patients underwent3 NAFL treatment sessions (1 month apart) on1 side of their face, and then the treated side was compared with the untreated side between sessions. The results showed significant improvements in facial skin laxity, wrinkles, and pores as well as reduced sagging of the nasolabial groove on the NAFL-treated side compared with the untreated side (baseline). Additionally, the study compared NAFL with microneedle fractional radiofrequency (MFR) and found similar outcomes for MFR-treated skin but that NAFL offered a more convenient treatment option due to itsshorter downtime.11
Nonablative lasers have emerged as a gentle yet highly effective approach to achieving healthier skin. They utilize precise photothermolysis to stimulate collagen and elastin production and promote dermal wound healing with minimal downtime. These lasers can reduce the development of KC and improve the overall health of sun-damaged skin. NAFLs have also demonstrated remarkable success in ameliorating photodamage and improving hyperpigmentation, telangiectasias, skin laxity, and tactile roughness.
In conclusion, nonablative lasers represent a promising solution for individuals seeking healthier and more youthful-looking skin with fewer associated risksand downtime.
Nina Venturaisa doctor of osteopathic medicine candidate and a master of health services administration candidate at Lake Erie College of Osteopathic Medicine in Elmira, New York.
Mara C. WeinsteinVelez, MD, FAAD, is a board-certified dermatologist and the director of cosmetic and laser dermatology at University of Rochester Medical School in New York.
References
Visit link:
Nonablative Lasers Offer a Gentle Approach to Healthy Skin - Dermatology Times
- Recognizing Topical Steroid Withdrawal and Advancing Therapeutic Precision - Dermatology Times - June 10th, 2025 [June 10th, 2025]
- Examining the Halfway Mark of 2025 in Dermatology - Dermatology Times - June 10th, 2025 [June 10th, 2025]
- Summertime skin protection strategies | Dermatology Associates of Ithaca - 607 News Now - June 10th, 2025 [June 10th, 2025]
- Retinol Market Set to Witness Surge in Dermatology and Skincare Applications | RoC, The Ordinary - openPR.com - June 10th, 2025 [June 10th, 2025]
- Chronic Itch Pathophysiology and Therapeutic Advances - Dermatology Times - June 10th, 2025 [June 10th, 2025]
- Adam Friedman, MD, FAAD: Spotlighting Disparities in Lichen Planus Screening and Treatment - Dermatology Times - June 10th, 2025 [June 10th, 2025]
- Addressing Overlapping Pathophysiology and Patient Burden in Atopic Dermatitis and Alopecia Areata - Dermatology Times - June 10th, 2025 [June 10th, 2025]
- Road to RAD: Whats Next in the AD Pipeline? - Dermatology Times - June 10th, 2025 [June 10th, 2025]
- Revolutionizing Onco-Dermatology Techniques and Managing Adverse Effects - CancerNetwork - June 1st, 2025 [June 1st, 2025]
- Practical Strategies for Harnessing AI and Social Media in Dermatology - Dermatology Times - June 1st, 2025 [June 1st, 2025]
- The Medical Sisterhood: Expertise into InfluenceOwning the Podium in Dermatology, with Amy Spizuoco, DO - HCPLive - June 1st, 2025 [June 1st, 2025]
- Recognizing Melanoma and Skin Cancer Awareness Month 2025 - Dermatology Times - June 1st, 2025 [June 1st, 2025]
- Clinical and Conference Insights from a Dermatology PA Leader - Dermatology Times - June 1st, 2025 [June 1st, 2025]
- Beyond the Clinic: How the Mobile Destination Healthy Skin Initiative Saved Peter Graylins Life - Dermatology Times - June 1st, 2025 [June 1st, 2025]
- Integrating Ruxolitinib, Excimer Laser, and Emerging Therapies for Vitiligo - Dermatology Times - June 1st, 2025 [June 1st, 2025]
- Some Major Key Players In The AI-Powered Drug Discovery in Dermatology Market: - InsightAce Analytic - June 1st, 2025 [June 1st, 2025]
- Revolutionizing Acne Treatments and Skin Care with Cold Plasma Technology - Dermatology Times - May 21st, 2025 [May 21st, 2025]
- Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor - Dermatology Times - May 21st, 2025 [May 21st, 2025]
- Weighing In on Biologics and JAK Inhibitors for Atopic Dermatitis - Dermatology Times - May 21st, 2025 [May 21st, 2025]
- Expert Insights Highlight Novel ITK Inhibition With Soquelitinib for AD - Dermatology Times - May 21st, 2025 [May 21st, 2025]
- Health-E Commerce launches Collaboration with Healthcare Marketplace Sesame to Expand Access to Mental Health and Dermatology Care on FSA Store and... - May 21st, 2025 [May 21st, 2025]
- Dermatology of the Rockies Among First in Colorado to Offer Latest Noninvasive Brain Stimulation Technology to Optimize Mental Health - Morningstar - May 21st, 2025 [May 21st, 2025]
- Latest Acne and Rosacea Therapies Unveiled at Dermatology Week - HMP Global Learning Network - May 21st, 2025 [May 21st, 2025]
- Lilly Dermatology and UPHS talk Skin Cancer Awareness - WZMQ 19 News - May 12th, 2025 [May 12th, 2025]
- Vet Watch: Tips and pitfalls of dermatology in the new age of isoxazolines - DVM360 - May 12th, 2025 [May 12th, 2025]
- Missed Diagnoses, Missed Opportunities: Closing the Gap in Skin Cancer for Patients of Color - Dermatology Times - May 12th, 2025 [May 12th, 2025]
- The State of Melanoma Care: Advances, Access, and the Road Ahead - Dermatology Times - May 12th, 2025 [May 12th, 2025]
- Protagonist Announces Icotrokinra Phase 3 Data on Difficult-to-Treat Scalp and Genital Psoriasis and Preclinical Data on PN-881 Presented at the... - May 12th, 2025 [May 12th, 2025]
- Business Bites: Job Service, Epiphany Dermatology moving; student art exhibition; local yarn shop day; fundraising to save historic barn; block party;... - April 27th, 2025 [April 27th, 2025]
- Dermatology Excimer Laser Market Size to Hit USD 1,725.35 Million by 2034 - Precedence Research - April 27th, 2025 [April 27th, 2025]
- Skin of Color Dermatology Substantially Improved in Last 20 Years - Drug Topics - April 19th, 2025 [April 19th, 2025]
- How Anastasia Georgievskaya and SkinGPT Are Addressing Gaps in the Dermatology Industry - Dermatology Times - April 19th, 2025 [April 19th, 2025]
- Shawn Kwatra, MD, Endowed as Dr. Joseph Warren Burnett Professor of Dermatology at the University of Maryland School of Medicine - Dermatology Times - April 19th, 2025 [April 19th, 2025]
- Utility of Head-to-Head Studies in Atopic Dermatitis and Future Research Directions - Dermatology Times - April 19th, 2025 [April 19th, 2025]
- Treating Rosacea and Other Concerns with Generative Skins Ingredient Library - Dermatology Times - April 19th, 2025 [April 19th, 2025]
- Case 1: Experts on a GPP Emergency Case and Effisayil 1 Trial Results - Dermatology Times - April 19th, 2025 [April 19th, 2025]
- Utility of Head-to-Head Studies in Psoriasis Management - Dermatology Times - April 19th, 2025 [April 19th, 2025]
- AAD Reading Room | DEI in Dermatology: Past, Present -- and Future - MedPage Today - April 10th, 2025 [April 10th, 2025]
- Epidemiological Study on Palmoplantar Pustulosis in Korea Highlights Disease Burden and Treatment Gaps - Dermatology Times - April 10th, 2025 [April 10th, 2025]
- Championing Patient and Consumer Safety in Dermatology - Dermatology Times - April 10th, 2025 [April 10th, 2025]
- Addressing Diagnostic Ambiguity and Expanding Therapeutic Options in CHE - Dermatology Times - April 10th, 2025 [April 10th, 2025]
- The Future of laBCC Treatment with Vishal Patel, MD, FAAD, FACMS - Dermatology Times - April 10th, 2025 [April 10th, 2025]
- Shaping the Future of Dermatology With Insights From AAD 2025 and Beyond - Dermatology Times - April 10th, 2025 [April 10th, 2025]
- Overcoming Therapeutic Inertia in a 25-Year-Old Man with Moderate to Severe Atopic Dermatitis - Dermatology Times - April 10th, 2025 [April 10th, 2025]
- Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 3 - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Top 5 Articles of the Month: March - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Talking to Patients on Sunscreen Application and the Effects of Visible Light - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Challenges and Unmet Needs in Treating Pediatric Atopic Dermatitis - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Clinical Experience and Diagnosis of GPP - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Gene Expression Profiling and Other Molecular Tests Utilized for Melanoma and Squamous Cell Carcinoma - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Fixed-Dose Acne Treatment Gel is Safe and Effective for Hispanic Patients, According to Post-Hoc Analysis - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- CBD and CBG Ointment Improved Skin in Patients with Atopic Dermatitis - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Utilizing Gene Expression Profiling to Avoid Unnecessary Interventions in a 72-Year-Old Woman With Melanoma - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Hims & Hers shutters Apostrophe in favor of its own tele-dermatology offerings - Fierce healthcare - March 15th, 2025 [March 15th, 2025]
- Closing Out AAD With Dermatology Times Editor in Chief - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- Improving Patient Care in Dermatology Through Data, Innovation, Advocacy: AAD 2025 Recap - AJMC.com Managed Markets Network - March 15th, 2025 [March 15th, 2025]
- Inflammatory Arthropathy Risk Increased in Patients With Hidradenitis Suppurativa - Dermatology Advisor - March 15th, 2025 [March 15th, 2025]
- Expert Perspectives: Dermatology's Top Story to Watch in 2025 - MD Magazine - March 15th, 2025 [March 15th, 2025]
- Whats New in Dermatology for Pigmentary Disorders, with Andrew Alexis, MD, MPH - MD Magazine - March 15th, 2025 [March 15th, 2025]
- Home Phototherapy Proves Effective and Preferred in LITE Study for Psoriasis Treatment - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- Efficacy, Safety, and Role in Therapy of JAK Inhibitors for Atopic Dermatitis - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- Reviving the Classics: The Role of Older Medications in Modern Dermatology - AJMC.com Managed Markets Network - March 15th, 2025 [March 15th, 2025]
- Dermatology Therapeutics: Updates for Primary Care from AAD 2025 - Patient Care Online - March 15th, 2025 [March 15th, 2025]
- Advances in Dermatology Therapeutics: Key Insights from AAD 2025 - Patient Care Online - March 15th, 2025 [March 15th, 2025]
- The Impact of JAK Selectivity in Atopic Dermatitis Treatment - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- Social Drivers of Health Success Stories in Dermatology | AAD 2025 - Managed Healthcare Executive - March 15th, 2025 [March 15th, 2025]
- Improving Acne Treatment Through Antibiotic Stewardship and Gut-Skin Health - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- Advancing Recognition and Treatment of Allergic Contact Dermatitis - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- Lebrikizumab Shows 3-Year Sustained Efficacy in AD - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- AAD 2025: Galderma to Present Extensive Updates From Across Its Dermatology Portfolio, Demonstrating Its Category Leadership and Strong Momentum -... - March 5th, 2025 [March 5th, 2025]
- What to Look Forward to at the American Academy of Dermatology Annual Meeting 2025 - MD Magazine - March 5th, 2025 [March 5th, 2025]
- Recognizing the Achievements of Women in Dermatology - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- The Solar Spectrum and Impact on Skin Health - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- The Undetectable Era: How Patients Are Shifting Towards More Natural-Looking Results at the Clinic - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- Researchers overseas: Radiology has become indispensable to dermatology - Radiology Business - March 5th, 2025 [March 5th, 2025]
- Defining Alopecia Areata Severity and Navigating Treatment Options - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- Acne and TikTok: What Do Dermatologists Need to Know? - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- Celebrating Womens History Month with Mindy Haws, MD, and the LIMITLESS Initiative - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- A Case-Based Approach to Topical and Nonsteroidal AD Management - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- Dermatology Partners Opens State-of-the-Art Dermatopathology Laboratory - citybiz - February 25th, 2025 [February 25th, 2025]